[1] Leise MD, Poterucha JJ,Kamath PS,et al.Management of hepatic encephalopathy in the hospital.Mayo Clin Proc,2014,89:241-253. [2] Gow AG.Hepatic Encephalopathy.Vet Clin North Am Small Anim Pract,2017,47:585-599. [3] 徐秋仙,张振纲,聂华,等.非生物型人工肝对乙型肝炎肝衰竭干预时机的临床研究.中西医结合肝病杂志,2015,25:133-136. [4] Stenbøg P, Busk T,Larsen FS. Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange. Metab Brain Dis,2013, 28: 333-335. [5] 中华医学会消化病学分会,中华医学会肝病学分会. 中国肝性脑病诊治共识意见(2013年,重庆).中华肝脏病杂志,2013, 21: 641-651. [6] Gonzalez HC,Jafri SM,Gordon SC.Management of Acute Hepatotoxicity Including Medical Agents and Liver Support Systems. Clin Liver Dis,2017,21:163-180. [7] Sarin SK, Choudhury A.Acute-on-chronic liver failure:terminology,mechanisms and management.Nat Rev Gastroenterol Hepatol, 2016,13:131-149. [8] Shen Y,Wang XL,Wang B,et al.Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure:A Time Series-Based Meta-Analysis. Medicine(Baltimore),2016,95: e2506. [9] Ide K, Muguruma T,Shinohara M,et al.Continuous Veno-Venous Hemodiafiltration and Plasma Exchange in Infantile Acute Liver Failure. Pediatr Crit Care Med,2015, 16:e268-e274. [10] Zhou PQ,Zheng SP,Yu M,et al.Prognosis of acute-on-chronic liver failure patients treated with arti?cial liver support system.World J Gastroenterol,2015, 21:9614-9622. [11] 边春香,张槟,吴君,等.综合治疗加血浆置换治疗肝性脑病的疗效探讨.临床肝胆病杂志,2009,25:219-220. [12] Li M,Wang Z,Wang Y,et al.Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure.Exp Ther Med,2016,12: 2582-2584. |